Latest ProteoGenix News & Updates

See the latest news and media coverage for ProteoGenix. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
ProteoGenix

Supplier of life science reagents and custom services

proteogenix-products.com
Headquarters
Schiltigheim, France
Founded year
2003
Company type
Private company
Number of employees
10–60

Last updated

Latest news about ProteoGenix

In short: ProteoGenix expanded its diagnostic partnerships and AI-driven antibody capabilities while its leadership faced legal allegations in France.

Company announcements

  • ProteoGenix

    ProteoGenix de-risks antibody humanization with AI-guided design

    They humanized a French biotech's lead antibody for cervical cancer therapy, reducing immunogenicity risk and improving binding up to 2.6-fold in 3 weeks.

  • ProteoGenix

    ProteoGenix partners with MicrosensDx on sepsis diagnostic

    They design antibodies distinguishing protein isoforms for the ox-PTX3 ELISA test. Promising results achieved; scaling to clinical trials.

  • ProteoGenix

    ProteoGenix powers groundbreaking endometriosis research

    They collaborated with Fondazione Italiana Endometriosi and Prof. Pietro Giulio Signorile to deliver the antibody discovery pipeline for patent WO2025062271A1 targeting NTRK2.

  • ProteoGenix

    ProteoGenix accelerates neurology diagnostics with AI-driven antibody affinity maturation

    They boosted a mouse antibody's binding affinity 20-fold for neurodegenerative disease detection using paratope-epitope mapping, AI-guided mutations, and wet-lab validation.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about ProteoGenix

Track ProteoGenix and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

ProteoGenix competitors & trending companies

Browse news for competitors to ProteoGenix and other trending companies.